Literature DB >> 22526366

A national registry of haemoglobinopathies in Greece: deducted demographics, trends in mortality and affected births.

Ersi Voskaridou1, Vasilis Ladis, Antonis Kattamis, Eleni Hassapopoulou, Marina Economou, Alexandra Kourakli, Konstantinos Maragkos, Kalliopi Kontogianni, Stilianos Lafioniatis, Eleni Vrettou, Freideriki Koutsouka, Alexandros Papadakis, Andreas Mihos, Eftihios Eftihiadis, Kallistheni Farmaki, Ourania Papageorgiou, Georgia Tapaki, Polixeni Maili, Maria Theohari, Marouso Drosou, Zafeiris Kartasis, Maria Aggelaki, Artemis Basileiadi, Ioannis Adamopoulos, Ioannis Lafiatis, Athanasios Galanopoulos, Georgios Xanthopoulidis, Efthimia Dimitriadou, Agapi Mprimi, Maria Stamatopoulou, Elanso Damba Haile, Maria Tsironi, Athanasios Anastasiadis, Maria Kalmanti, Margarita Papadopoulou, Evaggelia Panori, Peristera Dimoxenou, Antigoni Tsirka, Dimitrios Georgakopoulos, Pantelis Drandrakis, Dionisia Dionisopoulou, Androniki Ntalamaga, Ioannis Davros, Markisia Karagiorga.   

Abstract

Haemoglobinopathies are the most common hereditary disorders in Greece. Although there is a successful national prevention program, established 35 years ago, there is lack of an official registry and collection of epidemiological data for haemoglobinopathies. This paper reports the results of the first National Registry for Haemoglobinopathies in Greece (NRHG), recently organized by the Greek Society of Haematology. NRHG records all patients affected by thalassaemia major (TM), thalassaemia intermedia (TI), "H" Haemoglobinopathy (HH) and sickle cell disease (SCD). Moreover, data about the annual rate of new affected births along with deaths, between 2000 and 2010, are reported. A total of 4,506 patients are registered all over the country while the number of affected newborns was significantly decreased during the last 3 years. Main causes for still having affected births are: (1) lack of medical care due to financial reasons or low educational level; (2) unawareness of time limitations for prenatal diagnosis (PD); due either to obstetricians' malpractice or to delayed demand of medical care of couples at risk; and (3) religious, social or bioethical reasons. Cardiac and liver disorders consist main causes for deaths while life expectancy of patients lengthened after 2005 (p < 0.01). The NRHG of patients affected by haemoglobinopathies in Greece provides useful data about the haemoglobinopathies in the Greek population and confirms the efficacy of the National Thalassaemia Prevention Program on impressively decreasing the incidence of TM and sickle cell syndromes.

Entities:  

Mesh:

Year:  2012        PMID: 22526366     DOI: 10.1007/s00277-012-1465-7

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  24 in total

1.  Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overload.

Authors:  Yesim Aydinok; Antonis Kattamis; M Domenica Cappellini; Amal El-Beshlawy; Raffaella Origa; Mohsen Elalfy; Yurdanur Kilinç; Silverio Perrotta; Zeynep Karakas; Vip Viprakasit; Dany Habr; Niculae Constantinovici; Junwu Shen; John B Porter
Journal:  Blood       Date:  2015-05-01       Impact factor: 22.113

2.  An online open-source tool for automated quantification of liver and myocardial iron concentrations by T2* magnetic resonance imaging.

Authors:  K-A Git; L A B Fioravante; J L Fernandes
Journal:  Br J Radiol       Date:  2015-06-29       Impact factor: 3.039

Review 3.  Iron overload in thalassemia: different organs at different rates.

Authors:  Ali T Taher; Antoine N Saliba
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 4.  Dual-energy X-ray absorptiometry pitfalls in Thalassemia Major.

Authors:  Fabio Pellegrino; Maria Chiara Zatelli; Marta Bondanelli; Aldo Carnevale; Corrado Cittanti; Monica Fortini; Maria Rita Gamberini; Melchiore Giganti; Maria Rosaria Ambrosio
Journal:  Endocrine       Date:  2019-07-12       Impact factor: 3.633

Review 5.  Transition of Thalassaemia and Friedreich ataxia from fatal to chronic diseases.

Authors:  Annita Kolnagou; Christina N Kontoghiorghe; George J Kontoghiorghes
Journal:  World J Methodol       Date:  2014-12-26

Review 6.  Differences in the clinical and genotypic presentation of sickle cell disease around the world.

Authors:  Santosh L Saraf; Robert E Molokie; Mehdi Nouraie; Craig A Sable; Lori Luchtman-Jones; Gregory J Ensing; Andrew D Campbell; Sohail R Rana; Xiao M Niu; Roberto F Machado; Mark T Gladwin; Victor R Gordeuk
Journal:  Paediatr Respir Rev       Date:  2013-11-15       Impact factor: 2.726

Review 7.  Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease.

Authors:  A D Dede; G Trovas; E Chronopoulos; I K Triantafyllopoulos; I Dontas; N Papaioannou; S Tournis
Journal:  Osteoporos Int       Date:  2016-08-08       Impact factor: 4.507

8.  Dynamics of sickle cell disease as one of the determinants of quality of life.

Authors:  Maria Lúcia Ivo; Alexandra Maria Almeida Carvalho Pinto
Journal:  Rev Bras Hematol Hemoter       Date:  2013

9.  Evaluation of married haemoglobinopathic carrier couples for prevention of haemoglobinopathic births.

Authors:  Ersin Nazlıcan; Ozlem Celenk; Bayram Kerkez; Hakan Demirhindi; Muhsin Akbaba; Mustafa Kiremitçi
Journal:  Balkan Med J       Date:  2013-09-27       Impact factor: 2.021

Review 10.  β-Thalassemia.

Authors:  Raffaella Origa
Journal:  Genet Med       Date:  2016-11-03       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.